Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus

Covid-19: Oxford-AstraZeneca vaccine shows strong immune response

William Ukpe by William Ukpe
July 20, 2020
in Coronavirus
AstraZeneca suspends COVID-19 vaccine final stage trial over safety concerns, COVID-19: J&J starts vaccine trials on humans after success on monkeys
Share on FacebookShare on TwitterShare on Linkedin

A vaccine trial for the coronavirus by joint team of Oxford University researchers and pharmaceutical company, AstraZeneca Plc has shown strong immune response in early testings with humans. Lifting AstraZeneca shares as high as 10% in London today as a possible vaccine may come in the near future.

The report revealed that the trials showed protective neutralization of antibodies and immune t-cells aimed at the virus. Oxford’s Chief of Jenner Institute, Adrian Hill, said the research has recorded good immune system responses.

This also comes as another Biotech firm; Moderna Inc announced last week that its potential vaccine recorded higher levels of antibody research against the coronavirus.

RelatedPosts

U.S court renews suit against AstraZeneca Plc, Pfizer Inc, others

Moderna says its Covid vaccine generates strong immune response in 6-11 year-olds

Mr Hill also announced that it would be a necessary advantage if other companies and research groups report on vaccines, which will enable the world have more vaccines. This comes at a time when as much as 160 companies and groups globally are researching on a potential vaccine. However, the Oxford-AstraZeneca group seems to be far ahead of everyone as their vaccine reaches final stage of testing.

READ MORE: COVID-19: WHO stops hydroxychloroquine, HIV drugs trial after failure

AstraZeneca also announced that it can begin production of doses across the UK by September. Results from the group’s test with animals showed the vaccine was a catalyst for an immune response.

The US government has already pledged $1.2 billion towards the development of a potential vaccine with AstraZeneca, which would enable the United States government receive supplies by October.

The research revealed that surface spike protein from the virus was infused with genetic material, which tricks the immune system into fighting back, stimulating antibodies and white blood t-cells that help the immune system fight infections.

 

Related

Tags: Adrian HillAstraZeneca PlcJenner InstituteModerna IncOxford University researchers

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Mega Millions
Hot forex
Cornerstone
Polaris Bank
Access Bank
Bankers Committee
First bank


FCMB




    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • TrustBanc raises N5.85bn from Series 7 and 8 Commercial Papers; Issue Achieves 117% subscription
    • FIRS extends deadline for filing of 2022 Companies Income Tax returns to 31st August 2022
    • Lagos state government shuts down Redeemers School over death of pupil

    Follow us on social media:

    Recent News

    TrustBanc pays N4.2bn Commercial Paper proceeds at maturity

    TrustBanc raises N5.85bn from Series 7 and 8 Commercial Papers; Issue Achieves 117% subscription

    July 4, 2022
    FIRS calls for comprehensive revenue aggregation

    FIRS extends deadline for filing of 2022 Companies Income Tax returns to 31st August 2022

    July 4, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com